Schneider, M.; Potthoff, A.-L.; Evert, B.O.; Dicks, M.; Ehrentraut, D.; Dolf, A.; Schmidt, E.N.C.; Schäfer, N.; Borger, V.; Pietsch, T.;
et al. Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation Status. Pharmaceuticals 2021, 14, 195.
https://doi.org/10.3390/ph14030195
AMA Style
Schneider M, Potthoff A-L, Evert BO, Dicks M, Ehrentraut D, Dolf A, Schmidt ENC, Schäfer N, Borger V, Pietsch T,
et al. Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation Status. Pharmaceuticals. 2021; 14(3):195.
https://doi.org/10.3390/ph14030195
Chicago/Turabian Style
Schneider, Matthias, Anna-Laura Potthoff, Bernd O. Evert, Marius Dicks, Denise Ehrentraut, Andreas Dolf, Elena N. C. Schmidt, Niklas Schäfer, Valeri Borger, Torsten Pietsch,
and et al. 2021. "Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation Status" Pharmaceuticals 14, no. 3: 195.
https://doi.org/10.3390/ph14030195
APA Style
Schneider, M., Potthoff, A.-L., Evert, B. O., Dicks, M., Ehrentraut, D., Dolf, A., Schmidt, E. N. C., Schäfer, N., Borger, V., Pietsch, T., Westhoff, M.-A., Güresir, E., Waha, A., Vatter, H., Heiland, D. H., Schuss, P., & Herrlinger, U.
(2021). Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation Status. Pharmaceuticals, 14(3), 195.
https://doi.org/10.3390/ph14030195
